Health and Healthcare Systems

COVID-19: What you need to know about the coronavirus pandemic on 19 August

People sign up to take a coronavirus disease (COVID-19) test at a mobile testing van in Times Square in New York City, U.S., August 16, 2021. REUTERS/Jeenah Moon - RC2J6P9ZC1MU

People sign up for COVID-19 tests at a mobile van in Times Square, New York. Image: REUTERS/Jeenah Moon - RC2J6P9ZC1MU

Kate Whiting
Senior Writer, Forum Agenda
Share:
Our Impact
What's the World Economic Forum doing to accelerate action on Health and Healthcare Systems?
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

COVID-19

  • This daily round-up brings you a selection of the latest news and updates on the COVID-19 pandemic, as well as tips and tools to help you stay informed and protected.
  • Top stories: US to make COVID vaccine booster shots available from Sept; Haiti earthquake has stalled vaccination campaign; UK study shows vaccine efficacy weakens.
Have you read?

1. How COVID-19 is affecting the globe

Confirmed cases of COVID-19 have passed 209.3 million globally, according to Johns Hopkins University. The number of confirmed deaths stands at more than 4.39 million. More than 4.8 billion vaccination doses have been administered globally, according to Our World in Data.

Australian authorities began doling out emergency COVID-19 vaccine supplies on Thursday in the Sydney suburbs worst hit by an outbreak of the fast-moving Delta strain, as the country reported its biggest one-day rise in COVID-19 infections.

COVID-19 vaccine booster shots will be made widely available to Americans starting on 20 September, US health officials said on Wednesday, citing data showing diminishing protection from the initial vaccinations as infections rise from the Delta variant.

Discover

What is the World Economic Forum doing about access to vaccines?

The Philippines is allotting 45.3 billion pesos ($899 million) for COVID-19 booster shots under its 2022 budget, an official said, even as health authorities have yet to conclude there is a need for a third dose.

Norway will offer all 16- and 17-year-olds their first COVID-19 vaccine dose after those over 18 are fully vaccinated, its government said on Wednesday.

A case of COVID-19 has been confirmed at the Tokyo Paralympics Village, organizers said on Thursday, according to the BBC, just days before the Games are due to begin on 24 August.

Tunisia will relax its nightly curfew and cafes and restaurants will be allowed to remain open until 10pm, as part of an easing of anti-COVID restrictions, the Tunisian presidency said on Wednesday.

2. Haiti quake has stalled COVID-19 vaccination campaign

Haiti's COVID-19 vaccination campaign has been stalled by Saturday's quake and medical personnel, equipment and logistical support are urgently needed to help the country deal with multiple health emergencies, the Pan American Health Organization (PAHO) said on Wednesday.

PAHO Director Carissa Etienne told a virtual briefing that scores of hospitals in three regions had been either damaged or destroyed, while PAHO's Health Emergencies Director Ciro Ugarte said the vaccination campaign had stuttered as health teams switched their priorities.

"Our hearts go out to the people of Haiti, we are doing everything possible to assist Haitians in these difficult times," Etienne said. "The earthquake aftermath combined with the COVID-19 pandemic presents a very challenging situation.

"We hope that the international community can come together to provide the urgently-needed air and ground logistics support to evacuate patients and transport essential humanitarian supplies – this is needed now."

Share of people vaccinated against COVID-19
How the vaccine roll-out in Haiti compares with other countries. Image: Our World in Data

3. Study shows COVID-19 vaccine efficacy wanes under Delta

A British public health study has found that protection from either of the two most commonly used COVID-19 vaccines against the now prevalent Delta variant of the new coronavirus weakens within three months.

It also found that those who get infected after receiving two shots of either the Pfizer-BioNTech or the AstraZeneca vaccine may be of greater risk to others than under previous variants of the coronavirus.

Based on more than 3 million nose and throat swabs taken across Britain, the Oxford University study found that 90 days after a second shot of the Pfizer or AstraZeneca vaccine, their efficacy in preventing infections had slipped to 75% and 61% respectively.

That was down from 85% and 68%, respectively, seen two weeks after a second dose. The decline in efficacy was more pronounced among those aged 35 years and older.

"Both of these vaccines, at two doses, are still doing really well against Delta... When you start very, very high, you got a long way to go," said Sarah Walker, an Oxford professor of medical statistics and chief investigator for the survey.

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

These youth-led mental health solutions are making a difference worldwide

Elisha London

July 24, 2024

About Us

Events

Media

Partners & Members

  • Sign in
  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2024 World Economic Forum